Manufacturers Life Insurance Company, The Cue Biopharma, Inc. Transaction History

Manufacturers Life Insurance Company, The

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.49 - $5.92 $35,402 - $84,170	-14,218 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$4.41 - $12.28 $62,701 - $174,597	14,218 New	14,218 $69,000
Q1 2022 May 20, 2022	SELL	$4.41 - $12.28 $12,916 - $35,968	-2,929 Reduced 17.08%	14,218 $69,000
Q4 2021 Feb 16, 2022	SELL	$10.86 - $17.85 $5,419 - $8,907	-499 Reduced 2.83%	17,147 $194,000
Q3 2021 Nov 12, 2021	SELL	$10.06 - $15.3 $10,210 - $15,529	-1,015 Reduced 5.44%	17,646 $257,000
Q2 2021 Aug 12, 2021	SELL	$10.9 - $14.53 $5,123 - $6,829	-470 Reduced 2.46%	18,661 $217,000
Q1 2021 May 03, 2021	SELL	$11.2 - $16.09 $716 - $1,029	-64 Reduced 0.33%	19,131 $233,000
Q4 2020 Feb 12, 2021	BUY	$11.12 - $16.4 $28,567 - $42,131	2,569 Added 15.45%	19,195 $240,000
Q2 2020 Aug 10, 2020	BUY	$12.7 - $30.73 $40,005 - $96,799	3,150 Added 23.37%	16,626 $388,000
Q1 2020 May 15, 2020	SELL	$9.85 - $22.27 $344 - $779	-35 Reduced 0.26%	13,476 $191,000
Q4 2019 Feb 14, 2020	SELL	$7.06 - $17.47 $7,328 - $18,133	-1,038 Reduced 7.13%	13,511 $214,000
Q3 2019 Nov 12, 2019	BUY	$6.78 - $9.28 $8,556 - $11,711	1,262 Added 9.5%	14,549 $129,000
Q2 2019 Aug 14, 2019	BUY	$7.18 - $9.65 $95,400 - $128,219	13,287 New	13,287 $119,000
Q3 2018 Nov 14, 2018	SELL	$7.91 - $11.89 $119,868 - $180,181	-15,154 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$10.93 - $14.48 $81,811 - $108,382	7,485 Added 97.6%	15,154 $179,000
Q1 2018 May 15, 2018	BUY	$11.63 - $17.25 $89,190 - $132,290	7,669 New	7,669 $107,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $49.5M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.